No Data
No Data
State Street Corp's Strategic Reduction in Zentalis Pharmaceuticals Holdings
FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc
Stifel Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Maintains Target Price $9
Stifel analyst Bradley Canino maintains $Zentalis Pharmaceuticals(ZNTL.US)$ with a buy rating, and maintains the target price at $9.According to TipRanks data, the analyst has a success rate of 45.3%
Stifel Nicolaus Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Morgan Stanley Downgrades Zentalis Pharmaceuticals(ZNTL.US) to Hold Rating, Cuts Target Price to $8
Morgan Stanley analyst Michael Ulz downgrades $Zentalis Pharmaceuticals(ZNTL.US)$ to a hold rating, and adjusts the target price from $38 to $8.According to TipRanks data, the analyst has a success
Maintaining Hold on Zentalis Pharmaceuticals Amidst Positive Regulatory Developments and Upcoming Clinical Milestones